Last update 20 Sep 2024

Insulin lispro protamine(Eli Lilly Suzhou Pharmaceutical Co., Ltd.)

Overview

Basic Info

Drug Type
Biosimilar, Hormone
Synonyms-
Target
Action-
Mechanism
INSR agonists(Insulin receptor agonists)
Active Indication
Active Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
China (04 Feb 2013),
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus
China
04 Feb 2013
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 3
United States
01 Aug 2007
Diabetes Mellitus, Type 2Phase 3
Argentina
01 Aug 2007
Diabetes Mellitus, Type 2Phase 3
Brazil
01 Aug 2007
Diabetes Mellitus, Type 2Phase 3
Canada
01 Aug 2007
Diabetes Mellitus, Type 2Phase 3
Hungary
01 Aug 2007
Diabetes Mellitus, Type 2Phase 3
India
01 Aug 2007
Diabetes Mellitus, Type 2Phase 3
Mexico
01 Aug 2007
Diabetes Mellitus, Type 2Phase 3
Poland
01 Aug 2007
Diabetes Mellitus, Type 2Phase 3
Puerto Rico
01 Aug 2007
Diabetes Mellitus, Type 2Phase 3
South Korea
01 Aug 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
339
xjgapcgaqj(pidpwctbsu) = bbcipsxbbr gkfssjsjxx (psplsidurd, xzkccajeza - zotjuftkdg)
-
14 Dec 2010
insulin glargine
(Glargine)
xjgapcgaqj(pidpwctbsu) = dtwasxqdtv gkfssjsjxx (psplsidurd, xxniientqi - npsvhvsrrx)
Phase 3
471
xpxuhsqcev(axvnenseoa) = ydkffbbldz wkefftmawm (gezknxtodg )
Positive
01 Oct 2010
Insulin glargine
xpxuhsqcev(axvnenseoa) = jpfasptrfm wkefftmawm (gezknxtodg )
Phase 3
442
dquvupaiyl(sjilpfugox) = pxvxmdylld qmjwyyfseg (fpnbkvcqcb )
-
01 Feb 2010
dquvupaiyl(sjilpfugox) = unvxgjbhnu qmjwyyfseg (fpnbkvcqcb )
Phase 3
442
(Insulin Lispro Protamine Suspension)
wubnixlzjo(iysakrdvfy) = npskmrfosp dkaxoavfmn (bzvocwblqv, czarjsbwsx - rvboeemlhj)
-
04 Nov 2009
(Detemir)
wubnixlzjo(iysakrdvfy) = arzfjsqnbn dkaxoavfmn (bzvocwblqv, jqvkhohser - idqooyfqdi)
Phase 3
471
dftjmddeti(ylgrwzgswz) = rwlcqkvzgt qbhlpzuiiy (fgnixfglwb, yzobyatbup - tikludlbak)
-
03 Nov 2009
Insulin Glargine
(Glargine)
dftjmddeti(ylgrwzgswz) = uaevucuvpi qbhlpzuiiy (fgnixfglwb, kosxnfyqec - dsoabsbips)
Phase 3
387
(Insulin Lispro Protamine Suspension)
tfmdzddywy(qoixtttzpo) = eywvxnhmtz drxivxsdkx (qcoarqmbzr, jbwmqdsdec - cldtonkdha)
-
25 Sep 2009
tfmdzddywy(qoixtttzpo) = vhaxgoatch drxivxsdkx (qcoarqmbzr, jjrcismhax - lpvorjpvkc)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free